Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clare L Scott

Showing results (21-30 of 110) with videos related to

Pageof 11
Sort By:
The Journal of Clinical Investigation|October 25, 2008
Treatment of B-RAF mutant human tumor cells with a MEK inhibitor requires Bim and is enhanced by a BH3 mimeticMark S Cragg, Elisa S Jansen, Michele Cook, et al.
Cancers|August 14, 2025
Barriers and Breakthroughs in Precision Oncology: A National Registry Study of <i>BRCA</i> Testing and PARP Inhibitor Uptake in Women from the National Gynae-Oncology Registry (NGOR)Mahendra Naidoo, Clare L Scott, Mike Lloyd, et al.
Molecular Cancer Research : MCR|April 17, 2021
CHK2 Inhibition Provides a Strategy to Suppress Hematologic Toxicity from PARP InhibitorsZhen Xu, Cassandra J Vandenberg, Elizabeth Lieschke, et al.
Therapeutic Advances in Medical Oncology|January 31, 2024
The role of aberrant DNA methylation in cancer initiation and clinical impactsFranziska Geissler, Ksenija Nesic, Olga Kondrashova, et al.
BMC Neurology|October 28, 2006
Recovery of hand function through mental practice: a study protocolMagdalena Ietswaart, Marie Johnston, H Chris Dijkerman, et al.
Nature Reviews. Disease Primers|March 5, 2026
Ovarian cancerClare L Scott, Susana Banerjee, Florence Joly, et al.
Frontiers in Immunology|April 30, 2021
T-Cell Receptor Therapy in the Treatment of Ovarian Cancer: A Mini ReviewJessica W Y Wu, Sudiksha Dand, Lachlan Doig, et al.
Nature Medicine|August 8, 2012
Cisplatin-induced primordial follicle oocyte killing and loss of fertility are not prevented by imatinibJeffrey B Kerr, Karla J Hutt, Michele Cook, et al.
Cancers|January 8, 2025
Interleukin-6 Modulation in Ovarian Cancer Necessitates a Targeted Strategy: From the Approved to Emerging TherapiesHina Amer, Nirmala C Kampan, Catherine Itsiopoulos, et al.
Brain : a Journal of Neurology|April 26, 2011
Mental practice with motor imagery in stroke recovery: randomized controlled trial of efficacyMagdalena Ietswaart, Marie Johnston, H Chris Dijkerman, et al.
Pageof 11

Showing results (21-30 of 110) with videos related to

Sort By:
Pageof 11
The Journal of Clinical Investigation|October 25, 2008
Treatment of B-RAF mutant human tumor cells with a MEK inhibitor requires Bim and is enhanced by a BH3 mimeticMark S Cragg, Elisa S Jansen, Michele Cook, et al.
Cancers|August 14, 2025
Barriers and Breakthroughs in Precision Oncology: A National Registry Study of <i>BRCA</i> Testing and PARP Inhibitor Uptake in Women from the National Gynae-Oncology Registry (NGOR)Mahendra Naidoo, Clare L Scott, Mike Lloyd, et al.
Molecular Cancer Research : MCR|April 17, 2021
CHK2 Inhibition Provides a Strategy to Suppress Hematologic Toxicity from PARP InhibitorsZhen Xu, Cassandra J Vandenberg, Elizabeth Lieschke, et al.
Therapeutic Advances in Medical Oncology|January 31, 2024
The role of aberrant DNA methylation in cancer initiation and clinical impactsFranziska Geissler, Ksenija Nesic, Olga Kondrashova, et al.
BMC Neurology|October 28, 2006
Recovery of hand function through mental practice: a study protocolMagdalena Ietswaart, Marie Johnston, H Chris Dijkerman, et al.
Nature Reviews. Disease Primers|March 5, 2026
Ovarian cancerClare L Scott, Susana Banerjee, Florence Joly, et al.
Frontiers in Immunology|April 30, 2021
T-Cell Receptor Therapy in the Treatment of Ovarian Cancer: A Mini ReviewJessica W Y Wu, Sudiksha Dand, Lachlan Doig, et al.
Nature Medicine|August 8, 2012
Cisplatin-induced primordial follicle oocyte killing and loss of fertility are not prevented by imatinibJeffrey B Kerr, Karla J Hutt, Michele Cook, et al.
Cancers|January 8, 2025
Interleukin-6 Modulation in Ovarian Cancer Necessitates a Targeted Strategy: From the Approved to Emerging TherapiesHina Amer, Nirmala C Kampan, Catherine Itsiopoulos, et al.
Brain : a Journal of Neurology|April 26, 2011
Mental practice with motor imagery in stroke recovery: randomized controlled trial of efficacyMagdalena Ietswaart, Marie Johnston, H Chris Dijkerman, et al.
Pageof 11